Generated by Llama 3.3-70B| Medtronic | |
|---|---|
| Name | Medtronic |
| Type | Public |
| Traded as | NYSE: MDT |
| Industry | Medical equipment |
| Founded | 1949 |
| Founder | Earl Bakken, Palmer Hermundslie |
| Headquarters | Dublin, Ireland |
| Key people | Geoff Martha, Omar Ishrak |
Medtronic is a multinational medical technology company that develops, manufactures, and sells medical devices and therapies, including those for cardiovascular disease, diabetes, and spinal cord injuries. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and is headquartered in Dublin, Ireland, with operational headquarters in Minneapolis, Minnesota. Medtronic has a diverse portfolio of products and services, including those for surgical procedures, diagnostic imaging, and patient monitoring, and has collaborated with various organizations, such as Cleveland Clinic, Mayo Clinic, and Massachusetts Institute of Technology. Medtronic has also partnered with companies like Google, Microsoft, and IBM to develop innovative medical technologies.
Medtronic was founded in 1949 by Earl Bakken and Palmer Hermundslie in Minneapolis, Minnesota, and initially focused on repairing medical equipment, including devices from General Electric and Westinghouse Electric Corporation. In the 1950s, Medtronic began to develop its own medical devices, including the first pacemaker, which was designed by Earl Bakken and Norman Davies. The company went public in 1959 and began to expand its product line to include devices for cardiovascular surgery, such as those used in coronary artery bypass grafting procedures at Columbia University Medical Center and University of California, Los Angeles. Medtronic has since acquired several companies, including Guidant Corporation, Covidien, and Nutritionals, Inc., and has established partnerships with organizations like American Heart Association, American Diabetes Association, and National Institutes of Health.
Medtronic offers a wide range of medical devices and therapies, including those for cardiovascular disease, diabetes, neurological disorders, and orthopedic conditions. The company's product portfolio includes insulin pumps from MiniMed, defibrillators from Physio-Control, and spinal cord stimulators from Boston Scientific Corporation. Medtronic also provides services, such as medical imaging and patient monitoring, through its Covidien and Patient Monitoring divisions, which have collaborated with Siemens Healthineers, Philips Healthcare, and GE Healthcare. Additionally, Medtronic has developed artificial intelligence-powered medical devices, such as those used in robotic surgery at University of California, San Francisco and Johns Hopkins University, and has partnered with companies like NVIDIA Corporation and Intel Corporation to develop innovative medical technologies.
Medtronic has a strong commitment to research and development, with a focus on developing innovative medical devices and therapies, including those for regenerative medicine and personalized medicine. The company has established partnerships with various organizations, such as Stanford University, Massachusetts Institute of Technology, and University of Oxford, to develop new medical technologies, including those for gene therapy and stem cell therapy. Medtronic has also collaborated with companies like Johnson & Johnson, Pfizer, and Merck & Co. to develop new medical devices and therapies, and has invested in various research initiatives, such as the Medtronic Foundation, which supports research in medical technology and global health at institutions like Harvard University and University of Cambridge.
Medtronic is a publicly traded company listed on the NYSE under the ticker symbol MDT, and is headquartered in Dublin, Ireland, with operational headquarters in Minneapolis, Minnesota. The company is led by Geoff Martha, who serves as the CEO, and Omar Ishrak, who serves as the chairman of the board, and has a diverse board of directors, including representatives from Goldman Sachs, Microsoft, and 3M. Medtronic has a global presence, with operations in over 160 countries, including United States, China, Japan, and Germany, and has established partnerships with various organizations, such as World Health Organization, American Red Cross, and Bill and Melinda Gates Foundation, to support global health initiatives.
Medtronic has faced several controversies and recalls over the years, including recalls of its defibrillators and insulin pumps, which have been linked to adverse events and patient injuries at institutions like Food and Drug Administration and Centers for Disease Control and Prevention. The company has also faced criticism for its marketing practices and pricing strategies, which have been the subject of investigations by US Senate, US House of Representatives, and Federal Trade Commission. Additionally, Medtronic has faced lawsuits related to its medical devices, including those filed by American Association for Justice and Public Citizen, and has established a patient safety program to monitor and report adverse events related to its medical devices, in collaboration with organizations like Institute of Medicine and National Academy of Engineering.